Berksoy Şahin

1.5k total citations
59 papers, 840 citations indexed

About

Berksoy Şahin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Berksoy Şahin has authored 59 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Berksoy Şahin's work include Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Berksoy Şahin is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Berksoy Şahin collaborates with scholars based in Türkiye. Berksoy Şahin's co-authors include Semra Paydaş, Suzan Zorludemir, İsmail Oğuz Kara, Sinan Yavuz, Melek Ergin, Berna Bozkurt Duman, İlhan Tuncer, Gülfiliz Gönlüşen, Umut Dişel and Fikri Başlamıslı and has published in prestigious journals such as Nutrients, British Journal of Haematology and Cancers.

In The Last Decade

Berksoy Şahin

54 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berksoy Şahin Türkiye 17 322 177 169 165 159 59 840
J.F. Seymour Australia 17 372 1.2× 188 1.1× 256 1.5× 114 0.7× 250 1.6× 52 1.1k
Élisabeth Palazzo France 21 145 0.5× 150 0.8× 162 1.0× 161 1.0× 150 0.9× 51 1.4k
Yohei Seto Japan 20 138 0.4× 181 1.0× 97 0.6× 91 0.6× 263 1.7× 68 1.4k
Ling Yin Ho China 21 124 0.4× 250 1.4× 249 1.5× 148 0.9× 132 0.8× 51 1.5k
Geneviève Depresseux Belgium 15 146 0.5× 223 1.3× 127 0.8× 78 0.5× 73 0.5× 23 1.1k
Sinan Yavuz Türkiye 13 184 0.6× 88 0.5× 62 0.4× 209 1.3× 136 0.9× 51 615
Jess D. Edison United States 17 118 0.4× 178 1.0× 90 0.5× 194 1.2× 128 0.8× 39 1.5k
Saverio Fusilli Italy 18 119 0.4× 87 0.5× 249 1.5× 166 1.0× 74 0.5× 36 999
Fengchun Zhang China 20 225 0.7× 198 1.1× 215 1.3× 145 0.9× 167 1.1× 68 1.3k
Hakan Harputluoğlu Türkiye 14 364 1.1× 125 0.7× 127 0.8× 63 0.4× 63 0.4× 49 728

Countries citing papers authored by Berksoy Şahin

Since Specialization
Citations

This map shows the geographic impact of Berksoy Şahin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berksoy Şahin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berksoy Şahin more than expected).

Fields of papers citing papers by Berksoy Şahin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berksoy Şahin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berksoy Şahin. The network helps show where Berksoy Şahin may publish in the future.

Co-authorship network of co-authors of Berksoy Şahin

This figure shows the co-authorship network connecting the top 25 collaborators of Berksoy Şahin. A scholar is included among the top collaborators of Berksoy Şahin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berksoy Şahin. Berksoy Şahin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Şahin, Berksoy, et al.. (2024). Neoadjuvant chemoimmunotherapy for a patient with micro-stallete instabile gastric cancer resulted a pathological complete response. Hematology Transfusion and Cell Therapy. 46. 11–12.
4.
Şahin, Berksoy, et al.. (2024). SUCCESSFUL CHEMOTHERAPY ADMINISTRATION DESPITE HYPERSPLENISM AND PANCYTOPENIA: A CASE OF METASTATIC RECTAL ADENOCARCINOMA. Hematology Transfusion and Cell Therapy. 46. S68–S69.
6.
Şahin, Berksoy. (2017). Enlighting the Shadow for Advanced Hepatocellular Carcinoma: Immunotherapy with Immune Checkpoint Inhibitors. Journal of Gastrointestinal Cancer. 48(3). 288–290. 1 indexed citations
7.
Duman, Berna Bozkurt, et al.. (2015). ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine. Współczesna Onkologia. 3(3). 207–213. 18 indexed citations
8.
Günaldı, Meral, Çiğdem Usul Afşar, Berna Bozkurt Duman, et al.. (2015). Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncology Letters. 10(1). 439–442. 12 indexed citations
9.
Günaldı, Meral, Berna Bozkurt Duman, Çiğdem Usul Afşar, et al.. (2015). Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. Journal of Oncology Pharmacy Practice. 22(2). 242–247. 37 indexed citations
10.
Nazik, Hakan, et al.. (2014). KEMOTERAPİ ALAN MEME KANSERLİ HASTALARDA PROGRESİF GEVŞEME EGZERSİZLERİNİN UYKU KALİTESİ VE AĞRIYA ETKİSİ. Journal of Anatolia Nursing and Health Sciences. 17(3). 4 indexed citations
11.
Duman, Berna Bozkurt, Meral Günaldı, Çiğdem Usul Afşar, et al.. (2012). Retrospective Analysis of 498 Primary Soft Tissue Sarcomas in a Single Turkish Centre. Asian Pacific Journal of Cancer Prevention. 13(8). 4125–4128. 7 indexed citations
12.
Şahin, Berksoy, et al.. (2012). Nurse-assisted education and exercise decrease the prevalence and morbidity of lymphedema following breast cancer surgery.. PubMed. 17(3). 565–9. 15 indexed citations
13.
Duman, Berna Bozkurt, Berksoy Şahin, Melek Ergin, & Birol Güvenç. (2011). Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature. Medical Oncology. 29(2). 1223–1226. 29 indexed citations
14.
Kibar, Mustafa, Ali Fuat Yapar, Semra Paydaş, et al.. (2009). The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up. Nuclear Medicine Communications. 31(1). 59–66. 20 indexed citations
15.
Kara, İsmail Oğuz, Berksoy Şahin, & Ramazan Güneşaçar. (2007). Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies. Advances in Therapy. 24(4). 741–747. 5 indexed citations
16.
Kara, İsmail Oğuz, et al.. (2004). Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.. PubMed. 25(11). 1587–92. 9 indexed citations
17.
Paydaş, Semra, et al.. (2003). Prognostic Significance of Microvessel Density and Vascular Endothelial Growth Factor (VEGF) Expression in non-Hodgkin's Lymphoma. Leukemia & lymphoma. 44(12). 2089–2093. 61 indexed citations
18.
Paydaş, Semra, et al.. (2003). Vasculitis Associated with All Trans Retinoic Acid (ATRA) in a Case with Acute Promyelocytic Leukemia. Leukemia & lymphoma. 44(3). 547–548. 12 indexed citations
19.
Paydaş, Semra, Melek Ergin, Fikri Başlamıslı, et al.. (2002). Bone marrow necrosis: Clinicopathologic analysis of 20 cases and review of the literature. American Journal of Hematology. 70(4). 300–305. 97 indexed citations
20.
Paydaş, Semra, et al.. (1997). p53 Protein Expression in Gastrointestinal Lymphomas. Oncology. 54(1). 84–87. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026